Elie W. Akl

540 total citations
12 papers, 230 citations indexed

About

Elie W. Akl is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elie W. Akl has authored 12 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elie W. Akl's work include Bladder and Urothelial Cancer Treatments (4 papers), Urinary and Genital Oncology Studies (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Elie W. Akl is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Urinary and Genital Oncology Studies (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Elie W. Akl collaborates with scholars based in United States and Italy. Elie W. Akl's co-authors include David J. Kwiatkowski, Amin H. Nassar, Elio Adib, Sarah Abou Alaiwi, Alexander Gusev, Guru Sonpavde, Toni K. Choueiri, Tarek H. Mouhieddine, Damir Khabibullin and Marios Giannakis and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elie W. Akl

11 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elie W. Akl United States 7 104 98 79 52 35 12 230
Eungbae Lee South Korea 10 178 1.7× 107 1.1× 52 0.7× 64 1.2× 33 0.9× 24 304
Sanket Shah India 11 186 1.8× 89 0.9× 69 0.9× 41 0.8× 66 1.9× 26 323
Sook Kyung South Korea 8 105 1.0× 65 0.7× 104 1.3× 50 1.0× 12 0.3× 29 229
Wiebke Antonopoulos Germany 8 107 1.0× 49 0.5× 81 1.0× 40 0.8× 20 0.6× 11 206
Hiroki Harada Japan 10 122 1.2× 95 1.0× 104 1.3× 94 1.8× 80 2.3× 37 289
Hannah V. Woodcock United Kingdom 4 113 1.1× 166 1.7× 26 0.3× 30 0.6× 35 1.0× 10 290
Amanda J. Loch Canada 4 135 1.3× 63 0.6× 89 1.1× 44 0.8× 33 0.9× 5 210
Hirohiko Totsuka Japan 8 195 1.9× 98 1.0× 133 1.7× 87 1.7× 36 1.0× 11 317
Guangsheng Zhu China 10 138 1.3× 102 1.0× 90 1.1× 79 1.5× 36 1.0× 30 252
Mengxi Xiu China 9 175 1.7× 49 0.5× 58 0.7× 112 2.2× 21 0.6× 14 277

Countries citing papers authored by Elie W. Akl

Since Specialization
Citations

This map shows the geographic impact of Elie W. Akl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elie W. Akl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elie W. Akl more than expected).

Fields of papers citing papers by Elie W. Akl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elie W. Akl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elie W. Akl. The network helps show where Elie W. Akl may publish in the future.

Co-authorship network of co-authors of Elie W. Akl

This figure shows the co-authorship network connecting the top 25 collaborators of Elie W. Akl. A scholar is included among the top collaborators of Elie W. Akl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elie W. Akl. Elie W. Akl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Akl, Elie W., et al.. (2026). Sex‐Difference of Associations Between Cigarette Smoking and Myocardial Fibrosis: The Multi‐Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 15(5). e044664–e044664.
2.
Adib, Elio, Amin H. Nassar, Sarah Abou Alaiwi, et al.. (2022). Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology. Genome Medicine. 14(1). 39–39. 34 indexed citations
3.
Ramamurthy, Chethan, Amin H. Nassar, Sarah Abou Alaiwi, et al.. (2022). Prevalence of pathogenic germline cancer risk variants in testicular cancer patients: Identifying high risk groups. Urologic Oncology Seminars and Original Investigations. 40(3). 113.e9–113.e15. 1 indexed citations
4.
Sanin, Andres, Kosmas Kosmas, Ji Wang, et al.. (2021). Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex. Cancer Research. 81(8). 2086–2100. 8 indexed citations
5.
Adib, Elio, Talal El Zarif, Amin H. Nassar, et al.. (2021). CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. British Journal of Cancer. 126(5). 797–803. 18 indexed citations
6.
Adib, Elio, Amin H. Nassar, Elie W. Akl, et al.. (2021). CDKN2A Alterations and Response to Immunotherapy in Solid Tumors. Clinical Cancer Research. 27(14). 4025–4035. 68 indexed citations
7.
Alaiwi, Sarah Abou, Amin H. Nassar, Elio Adib, et al.. (2021). Trans-ethnic variation in germline variants of patients with renal cell carcinoma. Cell Reports. 34(13). 108926–108926. 20 indexed citations
8.
Adib, Elio, Talal El Zarif, Rohit Jain, et al.. (2021). FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma. SHILAP Revista de lepidopterología. 3(2). 169–172. 8 indexed citations
9.
Alaiwi, Sarah Abou, Amin H. Nassar, Elio Adib, et al.. (2021). Genomic landscape of variant urinary tumor histologies.. Journal of Clinical Oncology. 39(6_suppl). 467–467. 1 indexed citations
10.
Nassar, Amin H., Elio Adib, Elie W. Akl, et al.. (2021). CDKN2A alterations as markers of immune checkpoint blockade (ICB) resistance in urothelial carcinoma (UC).. Journal of Clinical Oncology. 39(6_suppl). 475–475. 4 indexed citations
11.
Adib, Elio, Rohit Jain, William Paul Skelton, et al.. (2021). Impact of FGFR2/3 activating genomic alterations on response to enfortumab vedotin in metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 39(6_suppl). 472–472. 4 indexed citations
12.
Alesi, Nicola, Elie W. Akl, Damir Khabibullin, et al.. (2021). TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nature Communications. 12(1). 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026